Get prepared with the key expectations. Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor ...

LOS GATOS, CA / ACCESS Newswire / April 22, 2025 /Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, announced today that it plans to release its first ...